Research & Development

EvoLiver Test Shows Promise for Early Detection of Liver Cancer
Research & Development EvoLiver Test Shows Promise for Early Detection of Liver Cancer

In a significant stride for cancer detection, Mursla Bio recently announced encouraging results from its multi-center clinical study, MEV01, which focuses on the early detection of liver cancer, particularly Hepatocellular Carcinoma (HCC), using their innovative dynamic biopsy technology. Conducted

Prenatal Screening and Genetic Insights in Fetal Congenital Heart Disease
Research & Development Prenatal Screening and Genetic Insights in Fetal Congenital Heart Disease

Congenital heart disease (CHD) is a significant cause of infant morbidity and mortality, characterized by structural abnormalities in the heart or great vessels present at birth. This article delves into the clinical features, genetic characteristics, and pregnancy outcomes of 471 cases of fetal

Revolutionizing Beauty and Health: NihonChojyu Clinic Expands to Thailand
Research & Development Revolutionizing Beauty and Health: NihonChojyu Clinic Expands to Thailand

The launch of an advanced cell restoration treatment in Thailand marks a significant milestone in the Thai-Japan partnership. NihonChojyu Clinic, established by Dr. Masatoshi Egoshi, is at the forefront of this healthcare innovation, emphasizing the restoration of health and beauty from the

Is Cetuximab More Effective Than Durvalumab for Head and Neck Cancer?
Research & Development Is Cetuximab More Effective Than Durvalumab for Head and Neck Cancer?

Head and neck cancers rank as the seventh most common type of cancer globally, significantly impacting smokers, drinkers, and individuals with HPV infections. Cisplatin, a standard chemotherapy drug, coupled with radiation therapy, remains the gold standard for treating these cancers. However, over

Long-Term Cognitive Safety of Short-Term Menopausal Hormone Therapy
Research & Development Long-Term Cognitive Safety of Short-Term Menopausal Hormone Therapy

Women in early postmenopause often face the decision of whether to undergo menopausal hormone therapy (MHT) to manage their symptoms, and concerns over potential cognitive side effects can impact this choice considerably. Recently published research by Carey Gleason and colleagues from the

Phen2Test: Enhancing Genetic Testing Decisions for Pediatric Rare Disorders
Research & Development Phen2Test: Enhancing Genetic Testing Decisions for Pediatric Rare Disorders

Rare diseases, though individually uncommon, collectively impact millions of people worldwide. Most of these conditions manifest in childhood, with genetic factors being the primary cause in about 80% of cases. Children with rare genetic disorders often endure prolonged diagnostic journeys

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later